CLONAZEPAM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clonazepam, and when can generic versions of Clonazepam launch?
Clonazepam is a drug marketed by Alembic, Barr, Endo Operations, Sun Pharm Inds Inc, Accord Hlthcare, Actavis Elizabeth, Aurobindo Pharma Usa, Chartwell Rx, Norvium Bioscience, Prinston Inc, Rubicon, Sandoz, Teva, and Watson Labs. and is included in sixteen NDAs.
The generic ingredient in CLONAZEPAM is clonazepam. There are ten drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clonazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clonazepam
A generic version of CLONAZEPAM was approved as clonazepam by TEVA on September 10th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLONAZEPAM?
- What are the global sales for CLONAZEPAM?
- What is Average Wholesale Price for CLONAZEPAM?
Summary for CLONAZEPAM
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 16 |
| Finished Product Suppliers / Packagers: | 32 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| Clinical Trials: | 61 |
| Patent Applications: | 4,344 |
| Drug Prices: | Drug price information for CLONAZEPAM |
| Drug Sales Revenues: | Drug sales revenues for CLONAZEPAM |
| DailyMed Link: | CLONAZEPAM at DailyMed |
See drug prices for CLONAZEPAM
Recent Clinical Trials for CLONAZEPAM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Icahn School of Medicine at Mount Sinai | Phase 4 |
| Federal University of Minas Gerais | Phase 4 |
| El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | N/A |
Pharmacology for CLONAZEPAM
| Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for CLONAZEPAM
Anatomical Therapeutic Chemical (ATC) Classes for CLONAZEPAM
US Patents and Regulatory Information for CLONAZEPAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubicon | CLONAZEPAM | clonazepam | TABLET;ORAL | 075468-003 | Oct 6, 2000 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Chartwell Rx | CLONAZEPAM | clonazepam | TABLET;ORAL | 074925-003 | Sep 30, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | CLONAZEPAM | clonazepam | TABLET;ORAL | 074920-001 | Aug 4, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds Inc | CLONAZEPAM | clonazepam | TABLET;ORAL | 075423-001 | Apr 27, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
